A case of IMP-4-, OXA-421-, OXA-96-, and CARB-2-producing acinetobacter pittii sequence type 119 in Australia

Journal of Clinical Microbiology

Volumn 53, Issue 2, 2015, Pages 727-730

  Kamolvit, Witchuda ^a   Derrington, Petra ^b   Paterson, David L ^a,b   Sidjabat, Hanna E ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Pathology Queensland   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DORIPENEM; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; MINOCYCLINE; NETILMICIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SULTAMICILLIN; TETRACYCLINE; TIGECYCLINE; TIMENTIN; TOBRAMYCIN; BACTERIAL DNA; BETA LACTAMASE; DNA DIRECTED RNA POLYMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); RNA POLYMERASE BETA SUBUNIT;

ACINETOBACTER; ACINETOBACTER PITTII; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; AUSTRALIA; BACTERIAL GENE; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CARB 2 GENE; CASE REPORT; CLOSTRIDIUM DIFFICILE INFECTION; COLON RESECTION; DEBRIDEMENT; DIABETIC PATIENT; DNA SEQUENCE; FALLING; FEMALE; GENE IDENTIFICATION; HUMAN; HUMAN TISSUE; IMP 4 GENE; LEG AMPUTATION; MASS SPECTROMETER; MEDICAL HISTORY; MINIMUM INHIBITORY CONCENTRATION; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; OXA 421 GENE; OXA 51 GENE; OXA 96 GENE; TIBIA FRACTURE; ACINETOBACTER INFECTIONS; CHEMISTRY; ENZYMOLOGY; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR GENETICS; MULTILOCUS SEQUENCE TYPING; SECRETION (PROCESS); WOUND INFECTION;

ACINETOBACTER; ACINETOBACTER BAUMANNII;

ACINETOBACTER; ACINETOBACTER INFECTIONS; AGED; AUSTRALIA; BETA-LACTAMASES; DNA GYRASE; DNA, BACTERIAL; DNA-DIRECTED RNA POLYMERASES; FEMALE; GENOME, BACTERIAL; HUMANS; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA; WOUND INFECTION;

EID: 84921823308     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02726-14     Document Type: Article

References (34)

1. EUCAST. 2013. Breakpoint tables for interpretation of MICs and zone diameters. EUCAST, Basel, Switzerland. http://www.eucast.org/clinical-breakpoints/.Accessed1May.
2. Higgins PG, Lehmann M, Wisplinghoff H, Seifert H. 2010. gyrB multiplex PCR to differentiate between Acinetobacter calcoaceticus and Acinetobacter genomic species 3. J Clin Microbiol 48:4592-4594. http://dx.doi.org/10.1128/JCM.01765-10.
3. Gundi VA, Dijkshoorn L, Burignat S, Raoult D, La Scola B. 2009. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. Microbiology 155:2333-2341. http://dx.doi.org/10.1099/mic.0.026054-0.
4. Doi Y, Potoski BA, Adams-Haduch JM, Sidjabat HE, Pasculle AW, Paterson DL. 2008. Simple disk-based method for detection of Klebsiella pneumoniae carbapenemase-type beta-lactamase by use of a boronic acid compound. J Clin Microbiol 46:4083-4086. http://dx.doi.org/10.1128/JCM.01408-08.
5. Dortet L, Poirel L, Nordmann P. 2012. Rapid identification of carba-penemase types in Enterobacteriaceae and Pseudomonas spp. by using a biochemical test. Antimicrob Agents Chemother 56:6437-6440. http://dx.doi.org/10.1128/AAC.01395-12.
6. Picão RC, Andrade SS, Nicoletti AG, Campana EH, Moraes GC, Mendes RE, Gales AC. 2008. Metallo-beta-lactamase detection: comparative evaluation of double-disk synergy versus combined disk tests for IMP-, GIM-, SIM-, SPM-, or VIM-producing isolates. J Clin Microbiol 46:2028-2037. http://dx.doi.org/10.1128/JCM.00818-07.
7. Higgins PG, Perez-Llarena FJ, Zander E, Fernandez A, Bou G, Seifert H. 2013. OXA-235, a novel class D beta-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother 57:2121-2126. http://dx.doi.org/10.1128/AAC.02413-12.
8. Runnegar N, Sidjabat H, Goh HM, Nimmo GR, Schembri MA, Pater-son DL. 2010. Molecular epidemiology of multidrug-resistant Acineto-bacter baumannii in a single institution over a 10-year period. J Clin Mi-crobiol 48:4051-4056. http://dx.doi.org/10.1128/JCM.01208-10.
9. Yang HY, Lee HJ, Suh JT, Lee KM. 2009. Outbreaks of imipenem resistant Acinetobacter baumannii producing OXA-23 beta-lactamase in a tertiary care hospital in Korea. Yonsei Med J 50:764-770. http://dx.doi.org/10.3349/ymj.2009.50.6.764.
10. Poirel L, Walsh TR, Cuvillier V, Nordmann P. 2011. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis 70:119-123. http://dx.doi.org/10.1016/j.diagmicrobio.2010.12.002.
11. Sidjabat H, Nimmo GR, Walsh TR, Binotto E, Htin A, Hayashi Y, Li J, Nation RL, George N, Paterson DL. 2011. Carbapenem resistance in Klebsiella pneumoniae dueto the New Delhi metallo-beta-lactamase. Clin Infect Dis 52:481-484. http://dx.doi.org/10.1093/cid/ciq178.
12. Overbeek R, Olson R, Pusch GD, Olsen GJ, Davis JJ, Disz T, Edwards RA, Gerdes S, Parrello B, Shukla M, Vonstein V, Wattam AR, Xia F, Stevens R. 2014. The SEED and the rapid annotation of microbial genomes using subsystems technology (RAST). Nucleic Acids Res 42:D206-D214. http://dx.doi.org/10.1093/nar/gkt1226.
13. Chen Y, Cui Y, Pu F, Jiang G, Zhao X, Yuan Y, Zhao W, Li D, Liu H, Li Y, Liang T, Xu L, Wang Y, Song Q, Yang J, Liang L, Yang R, Han L, Song Y. 2012. Draft genome sequence of an Acinetobacter genomic species 3 strain harboring a bla(NDM-1) gene. J Bacteriol 194:204-205. http://dx.doi.org/10.1128/JB.06202-11.
14. Nemec A, Krizova L, Maixnerova M, van der Reijden TJ, Deschaght P, Passet V, Vaneechoutte M, Brisse S, Dijkshoorn L. 2011. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. Nov. (formerly Acinetobacter genomic species 3) and Acineto-bacter nosocomialis sp. Nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 162:393-404. http://dx.doi.org/10.1016/j.resmic.2011.02.006.
15. Wang X, Chen T, Yu R, Lu X, Zong Z. 2013. Acinetobacter pittii and Acinetobacter nosocomialis among clinical isolates of the Acinetobacter calcoaceticus-baumannii complex in Sichuan, China. Diagn Microbiol Infect Dis 76:392-395. http://dx.doi.org/10.1016/j.diagmicrobio.2013.03.020.
16. Yamamoto M, Nagao M, Matsumura Y, Hotta G, Matsushima A, Ito Y, Takakura S, Ichiyama S. 2013. Regional dissemination of Acinetobacter species harbouring metallo-beta-lactamase genes in Japan. Clin Microbiol Infect 19:729-736. http://dx.doi.org/10.1111/1469-0691.12013.
17. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640-2644. http://dx.doi.org/10.1093/jac/dks261.
18. Koh TH, Sng LH, Wang GC, Hsu LY, Zhao Y. 2007. IMP-4 and OXA beta-lactamases in Acinetobacter baumannii from Singapore. J Antimi-crob Chemother 59:627-632. http://dx.doi.org/10.1093/jac/dkl544.
19. OXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan. Antimicrob Agents Chemother 54:4575-4581. http://dx.doi.org/10.1128/AAC.00764-10.
20. Yu H, Peng Z, Zhan Y, Wang J, Yan Y, Chen M, Lu W, Ping S, Zhang W, Zhao Z, Li S, Takeo M, Lin M. 2011. Novel regulator MphX represses activation of phenol hydroxylase genes caused by a XylR/DmpR-type regulator MphR in Acinetobacter calcoaceticus. PLoS One 6:e17350. http://dx.doi.org/10.1371/journal.pone.0017350.
21. Jung J, Madsen EL, Jeon CO, Park W. 2011. Comparative genomic analysis of Acinetobacter oleivorans DR1 to determine strain-specific genomic regions and gentisate biodegradation. Appl Environ Microbiol 77:7418-7424. http://dx.doi.org/10.1128/AEM.05231-11.
22. Kamolvit W, Higgins PG, Paterson DL, Seifert H. 2014. Multiplex PCR to detect the genes encoding naturally occurring oxacillinases in Acineto-bacter spp. J Antimicrob Chemother 69:959-963. http://dx.doi.org/10.1093/jac/dkt480.
23. Peleg AY, Franklin C, Walters LJ, Bell JM, Spelman DW. 2006. OXA-58 and IMP-4 carbapenem-hydrolyzing beta-lactamases in an Acinetobacter junii blood culture isolate from Australia. Antimicrob Agents Chemother 50:399-400. http://dx.doi.org/10.1128/AAC.50.1.399-400.2006.
24. IMP-4, from Sydney, Australia, is closely related to other IncL/M plasmids. Antimicrob Agents Chemother 56:6029-6032. http://dx.doi.org/10.1128/AAC.01189-12.
25. IMP-4 in a patient with prolonged colonization by IMP-4-producing Enterobacteriaceae. J Clin Microbiol 52:3816-3818. http://dx.doi.org/10.1128/JCM.01491-14.
26. Huovinen P, Jacoby GA. 1991. Sequence of the PSE-1 beta-lactamase gene. Antimicrob Agents Chemother 35:2428-2430. http://dx.doi.org/10.1128/AAC.35.11.2428.
27. Higgins PG, Wisplinghoff H, Stefanik D, Seifert H. 2004. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemio-logically characterized multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother 48:1586-1592. http://dx.doi.org/10.1128/AAC.48.5.1586-1592.2004.
28. Chu YW, Afzal-Shah M, Houang ET, Palepou MI, Lyon DJ, Woodford N, Livermore DM. 2001. IMP-4, a novel metallo-beta-lactamase from nosocomial Acinetobacter spp. Collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother 45:710-714. http://dx.doi.org/10.1128/AAC.45.3.710-714.2001.
29. Huang LY, Lu PL, Chen TL, Chang FY, Fung CP, Siu LK. 2010. Molecular characterization of beta-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan. Antimicrob Agents Chemother 54:2699-2703. http://dx.doi.org/10.1128/AAC.01624-09.
30. Kim CK, Lee Y, Lee H, Woo GJ, Song W, Kim MN, Lee WG, Jeong SH, Lee K, Chong Y. 2010. Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182. Diagn Microbiol Infect Dis 68:432-438. http://dx.doi.org/10.1016/j.diagmicrobio.2010.07.014.
31. Roca I, Mosqueda N, Altun B, Espinal P, Akova M, Vila J. 2014. Molecular characterization of NDM-1-producing Acinetobacter pittii isolated from Turkey in 2006. J Antimicrob Chemother 69:3437-3438. http://dx.doi.org/10.1093/jac/dku306.
32. Yang J, Chen Y, Jia X, Luo Y, Song Q, Zhao W, Wang Y, Liu H, Zheng D, Xia Y, Yu R, Han X, Jiang G, Zhou Y, Zhou W, Hu X, Liang L, Han L. 2012. Dissemination and characterization of NDM-1-producing Acin-etobacter pittii in an intensive care unit in China. Clin Microbiol Infect 18:E506-E513. http://dx.doi.org/10.1111/1469-0691.12035.
33. Idzenga D, Schouten MA, van Zanten AR. 2006. Outbreak of Acineto-bacter genomic species 3 in a Dutch intensive care unit. J Hosp Infect 63:485-487. http://dx.doi.org/10.1016/j.jhin.2006.03.014.
34. Schleicher X, Higgins PG, Wisplinghoff H, Korber-Irrgang B, Kresken M, Seifert H. 2013. Molecular epidemiology of Acinetobacter baumannii and Acinetobacter nosocomialis in Germany over a 5-year period (2005-2009). Clin Microbiol Infect 19:737-742. http://dx.doi.org/10.1111/1469-0691.12026.